Sentinel Oncology
PrivateLast Round
Grant
Apr 1, 2018
Total Funding Raised
$10.27M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Sentinel Oncology is a biotechnology company that develops and commercializes new therapeutics for cancer patients.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sentinel Oncology Comparables
Compare Sentinel Oncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sareum Holdings plc | 85% | |
| Kazia Therapeutics | 77% | |
| PharmaEngine, Inc. | 76% |
Sentinel Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 1, 2018 | ||||
| Grant | Aug 4, 2017 | ||||
| Grant | Aug 8, 2015 | ||||
| Grant | Oct 31, 2013 | ||||
| Grant | Apr 19, 2011 | ||||
Grant | Jan 1, 2008 |
Sentinel Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eurostars SME programme | Grant |
| Cambridge Enterprise | Seed |
| Innovate UK | Grant |
| Medical Research Council | Grant |
| Wellcome Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 3500% MoM from 5 to 180.
- May 16, 2026
Monthly visitors increased 106% MoM.
Sentinel Oncology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sentinel Oncology's valuation, stock price, and market status.
Is Sentinel Oncology a public or private company?
Sentinel Oncology is a private company.
What is the current stock price of Sentinel Oncology?
Sentinel Oncology is a private company with no public stock price. No recent secondary market data is available.
How much is Sentinel Oncology worth (valuation)?
Valuation information for Sentinel Oncology is not publicly available.
Can I buy Sentinel Oncology stock?
Sentinel Oncology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sentinel Oncology's last funding round?
Sentinel Oncology's most recent funding round was Grant on April 1, 2018.
Who are the main investors in Sentinel Oncology?
Key investors in Sentinel Oncology include Eurostars SME programme, Cambridge Enterprise, Innovate UK, Medical Research Council, Wellcome Trust.
Will Sentinel Oncology IPO soon?
No public IPO plans have been announced for Sentinel Oncology.
How can I track Sentinel Oncology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sentinel Oncology's secondary market activity and sign up for updates.